# MEMANTINE HYDROCHLORIDE
> **ANDA214731** · Abbreviated New Drug Application (Generic) · Sponsor: NOVAST LABS LTD · Approved 2022-08-11
## Drug
- **FDA Application Number:** ANDA214731
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** MEMANTINE HYDROCHLORIDE
- **Generic name:** Memantine Hydrochloride
- **Active ingredients:** MEMANTINE HYDROCHLORIDE
- **Dosage form:** CAPSULE, EXTENDED RELEASE
- **Route:** ORAL
- **Marketing status:** None (Tentative Approval)
- **Sponsor:** NOVAST LABS LTD
- **First approval:** 2022-08-11
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214731)
---
*AI Analytics · CC0 1.0*